French officials are reporting dozens of heart incidents in experimental coronavirus treatments with hydroxychloroquine

France reported dozens of heart incidents linked to an anti-malaria drug President Trump has hyped as a possible treatment for the coronavirus.

Data released by France’s drug safety agency showed 43 cases of heart incidents linked to hydroxychloroquine, underscoring the risk of providing unproven treatments to COVID-19 patients.

“This initial assessment shows that the risks, in particular cardiovascular, associated with these treatments are very present and potentially increased in COVID-19 patients. Almost all of the declarations come from health establishments,” the agency said. “These drugs should only be used in hospitals, under close medical supervision.”

France has recorded 100 health incidents and four fatalities linked to experimental drugs for those with the coronavirus since late March. Three other patients had to be revived, and 82 incidents were considered “serious.”

The report comes as Trump repeatedly touts hydroxychloroquine as a possible coronavirus treatment, calling the drug a possible “game changer.”

[link to thehill.com (secure)]